Chelsea Counsel Company’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $363K | Hold |
9,360
| – | – | 0.18% | 80 |
|
|
2025
Q1 | $366K | Sell |
9,360
-20,000
| -68% | -$783K | 0.2% | 78 |
|
|
2024
Q4 | $1M | Hold |
29,360
| – | – | 0.52% | 42 |
|
|
2024
Q3 | $1.21M | Hold |
29,360
| – | – | 0.6% | 39 |
|
|
2024
Q2 | $1.14M | Hold |
29,360
| – | – | 0.57% | 38 |
|
|
2024
Q1 | $1.27M | Hold |
29,360
| – | – | 0.72% | 34 |
|
|
2023
Q4 | $1.1M | Hold |
29,360
| – | – | 0.58% | 40 |
|
|
2023
Q3 | $1.07M | Hold |
29,360
| – | – | 0.55% | 40 |
|
|
2023
Q2 | $1.06M | Hold |
29,360
| – | – | 0.52% | 42 |
|
|
2023
Q1 | $1.05M | Hold |
29,360
| – | – | 0.51% | 44 |
|
|
2022
Q4 | $1.04M | Hold |
29,360
| – | – | 0.52% | 46 |
|
|
2022
Q3 | $864K | Hold |
29,360
| – | – | 0.53% | 49 |
|
|
2022
Q2 | $1.6M | Hold |
29,360
| – | – | 0.82% | 31 |
|
|
2022
Q1 | $1.6M | Hold |
29,360
| – | – | 0.7% | 37 |
|
|
2021
Q4 | $1.62M | Hold |
29,360
| – | – | 0.7% | 36 |
|
|
2021
Q3 | $1.4M | Hold |
29,360
| – | – | 0.64% | 38 |
|
|
2021
Q2 | $1.46M | Hold |
29,360
| – | – | 0.67% | 38 |
|
|
2021
Q1 | $1.31M | Hold |
29,360
| – | – | 0.65% | 41 |
|
|
2020
Q4 | $1.35M | Hold |
29,360
| – | – | 0.7% | 39 |
|
|
2020
Q3 | $1.38M | Hold |
29,360
| – | – | 0.82% | 36 |
|
|
2020
Q2 | $1.5M | Hold |
29,360
| – | – | 0.92% | 33 |
|
|
2020
Q1 | $1.39M | Hold |
29,360
| – | – | 1.09% | 30 |
|
|
2019
Q4 | $1.73M | Hold |
29,360
| – | – | 1.05% | 30 |
|
|
2019
Q3 | $1.57M | Hold |
29,360
| – | – | 0.94% | 31 |
|
|
2019
Q2 | $1.47M | Hold |
29,360
| – | – | 0.79% | 37 |
|
|
2019
Q1 | $1.53M | Hold |
29,360
| – | – | 0.83% | 36 |
|
|
2018
Q4 | $1.4M | Hold |
29,360
| – | – | 0.85% | 34 |
|
|
2018
Q3 | $1.47M | Hold |
29,360
| – | – | 0.77% | 37 |
|
|
2018
Q2 | $1.48M | Buy |
+29,360
| New | +$1.48M | 0.88% | 37 |
|